DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Gane E, Nahass R, Luketic V. et al.
Efficacy of 12 or 18 Weeks of Grazoprevir Plus Elbasvir with Ribavirin in Treatment-Naive, Noncirrhotic Hcv Genotype 3-Infected Patients.
Journal of hepatology 2015;
62: S621-S621
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.